Medical and Pharmaceutical bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test It will be issued within 3 months provided that there are no opposition filings made by third parties Rowan DunneJanuary 22, 2025
Science and Research IGM Biosciences slides by 66% on discontinued drug development and lay offs The biotech company has put the halt on 2 therapeutics used to treat arthritis, lupus and myasthenia gravis Rowan DunneJanuary 10, 2025
Medical and Pharmaceutical Roche secures rights to Chinese biotech company’s small cell lung cancer drug Innovent Biologics will receive up to US$1 billion in milestone payments and royalties Rowan DunneJanuary 3, 2025
Medical and Pharmaceutical Portage Biotech soars after initiating proceedings for iOx Therapeutics sale The stock went up by over 185% after the LOI was announced Rowan DunneDecember 17, 2024
Medical and Pharmaceutical MIRA Pharma up 27% on ketamine analogue’s preclinical results for chemotherapy pain This pharmaceutical company is also developing a synthetic cannabinoid drug to treat anxiety and cognitive decline Rowan DunneOctober 30, 2024
Medical and Pharmaceutical South Korea’s Yuhan has 690% profit spike on U.S. lung cancer drug sales Lazertinib, developed in partnership with Janssen Biotech, received FDA approval in August Rowan DunneOctober 28, 2024
Medical and Pharmaceutical Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days Developing drugs for the treatment of epilepsy, depression, obesity and other conditions is the company's forte Rowan DunneOctober 18, 2024